The Global Pharmaceutical Industry
AN EXECUTIVE SUMMARY PRESENTING THE FINDINGS OF THE STUDY
A REPORT FORMATTED IN SLIDES, OPERATIONAL AND SYNTHETIC
THE STUDY OF THE GLOBAL MARKET AND THE ACTIVITY OF THE LEADERS
DETAILED ANALYSIS OF THE FINANCIAL PERFORMANCE OF MAJOR LISTED GROUPS
RANKINGS AND POSITIONING OF THE SECTOR'S LEADERS
1950 €
MARKET ANALYSIS IN THE LIGHT OF THE COVID-19 CRISIS
In addition to a comprehensive view of the sector's environment and demand (macroeconomic factors, changes brought about by digital transformation and ecological transition, etc.), the study provides our exclusive analysis of the past evolution of the global pharmaceutical industry and its prospects. In particular, it outlines the impact of the health crisis and the lessons to be learned from the current situation.
COMPANIES' BUSINESS STRATEGIES
Rationalisation of drug portfolios, redeployment of activities towards specialty medicine, continued innovation efforts, expansion and modernisation of production and innovation capacities, improvement of the environmental balance sheet, digital transformation of activities, pursuit of the external growth and partnership strategy: the report details the growth levers prioritised by the world leaders in the pharmaceutical industry, after analysing their main strengths and weaknesses.
EXPLANATION OF THE CHANGES IN THE COMPETITIVE LANDSCAPE
This report also provides an individualised and aggregated financial analysis of the operators' financial performance. In particular, it deciphers the evolution of sales and operating profit rate for the analysed companies.
Detailed plan
SUMMARY AND KEY PAGES OF THE REPORT
The summary provides all the elements needed to understand the major trends in the sector and foreseeable developments, drawing on analyses of the market outlook and the strategies of the companies.
Summary
Key slides
SCOPE OF THE REPORT
OVERVIEW
BUSINESS FUNDAMENTALS
THE SECTOR ENVIRONMENT
- Overview
- Economic factors
- The role of public authorities
- Socio-demographic factors
- Technological factors
- Environmental factors
THE GLOBAL PHARMACEUTICAL MARKET
- Global sales of medicines
- Breakdown of global drug sales by brand
- Global sales of speciality drugs
- Focus on biotech
- Focus on oncology
- Focus on immunology
- Geographical breakdown of the global pharmaceuticals market
- Outlook for the global pharmaceutical market
- Outlook for worldwide sales of medicines by therapeutic area
- Outlook for global drug sales by geographic region
- R&D expenditure
- Geographical breakdown of R&D expenditure
- Geographical distribution of new drug launches
- Global drug consumption
- Global drug consumption by region
- Geographical breakdown of global drug consumption
- Global drug consumption by therapeutic area
- Global exports of pharmaceutical products
- Pharmaceutical exporting countries
- Pharmaceutical product importing countries
- United States
- Europe
- China
- Japan
- Emerging countries
ACTIVITY AND LEADERS' PERFORMANCES
- Leaders' cumulative revenue
- Ranking by revenue
- Market share of market leaders
- Ranking by revenue growth rate
- Aggregate operating income of the leaders
- Leaders by EBIT margin
- Geographical breakdown of sales
- Key performance indicators
COMPETITIVE ENVIRONMENT
- Porter's 5 forces (Overview)
- Competitive intensity
- Threat of new entrants
- Government's influence
- Threat of substitutes
- Bargaining power of suppliers
LEADERS' STRATEGIES
- Overview
- Rationalisation of drug portfolios
- Redeployment of activities to specialty medicine
- Increasing R&D efforts
- Expanding and modernising production and innovation capacity
- Improving the environmental balance
- The digital transformation of businesses
- Pursuing the strategy of external growth and partnership
- Rankings of the 10 world leaders in the global pharmaceutical industry
- Key performance indicators of the 10 leaders (revenue growth and EBIT rate)
- SWOT analysis of the 10 leaders
- AbbVie
- AstraZeneca
- Bristol-Myers Squibb
- GSK
- Johnson & Jonhnson
- Merck & co
- Novartis
- Pfizer
- Roche
- Sanofi
Companies covered
Related reports
ACCESS THE REPORT
